Medical Developments International Ltd. engages in the manufacture and distribution of pharmaceutical drugs, medical, and veterinary equipment. The firm operates in two segments: Pain Management and Respiratory. The Pain Management segment is engaged in the supply of analgesia for acute and procedural pain. The firm manufactures an inhaled analgesic, Penthrox (the Green Whistle), at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability. The Respiratory segment is a supplier of respiratory products including asthma and chronic obstructive pulmonary disease (COPD) space chambers, peak flow meters, portable nebulizers and silicone face masks. The respiratory supplies into Australia, the United States of America, Europe, and Asia through partnerships with distributors.
Quelle est la performance du prix de l'action Medical Developments Internatio ?
Le prix actuel de Medical Developments Internatio est de $0.3706, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Medical Developments International Limited ?
Medical Developments International Limited appartient à l'industrie Pharmaceuticals et le secteur est Health Care
Quel est la capitalisation boursière de Medical Developments International Limited ?
La capitalisation boursière actuelle de Medical Developments International Limited est de $41.7M
Est-ce que Medical Developments International Limited est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 3 analystes ont établi des notations d'analystes pour Medical Developments International Limited, y compris 1 achat fort, 3 achat, 1 maintien, 0 vente et 1 vente forte